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PE/E IN BRIEF
• PE is a condition in pregnant
women marked by an increase
in blood pressure and protein in
urine after 20 weeks gestation;
eclampsia is a life-threatening
condition characterized by
convulsions in women with PE.
• Providing high quality ANC
improves the prevention and
early detection of PE and can
prevent its progression to
eclampsia.




• Intervention research occurred
in Cross River, Ebonyi, and Kogi
states, in 2016 and 2017, and
follow-up data was collected
from May-June 2018.
• 557 primary health care
(PHC) providers received
one month of training with
continuous mentorship to
identify hypertension and PE/E,
treat with MgSO4, and refer to
secondary facilities.
• The primary objective was to
facilitate task-shifting to PHC
providers of MgSO4 loading
dose administration and
secondary facility referral
for improved PE/E detection,
treatment, and management.
BACKGROUND
Despite global efforts to reduce preventable maternal and neonatal mortality, 
Nigeria’s maternal mortality ratio is estimated at 576 deaths per 100,000 live 
births and neonatal death is estimated at 37 per 1,000 live births  .
Maternal and newborn deaths due to pre-eclampsia and eclampsia (PE/E) are 
preventable, yet in Nigeria this is the most significant direct cause of maternal 
mortality. 
To appreciate the enormity of this problem at country and state levels, 
Population Council conducted a landscape analysis on PE/E in seven states 
in Nigeria were to understand Nigeria’s PE/E context, including assessment 
of evidence gaps over the last 15 years, and to determine priority areas for 
research and interventions around PE/E. This brief presents study 
findings from Kogi State on post-intervention landscape changes in:
• Programmatic and policy support for PE/E prevention and treatment;
• PHC facilities’ capacity to manage PE/E;
• Provider knowledge and competence in preventing, detecting, and
managing PE/E; and
• Community awareness, beliefs, and experiences around PE/E.
METHODS
This PE/E study is a pre/post, cross-sectional design with both qualitative 
and quantitative data collected at baseline (2015) and endline (2018). Data 
collection activities include in-depth interviews (IDIs) with policy makers, 
survivors of PE/E, and laboratory workers; focus group discussions (FDGs) 
with men and women from the community; and surveys and observations of 
client-provider interactions to assess provider capacity in antenatal care (ANC) 
and facility readiness and capacity to identify, treat, and manage PE/E at the 
primary and secondary levels.  
Table 1 describes data collection activities at baseline and endline in Kogi. 
The Ending Eclampsia project seeks to expand access 
to proven,underutilized interventions and commodities 
for the prevention, early detection, and treatment of 
pre-eclampsia and eclampsia and strengthen global 
partnerships. 
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Table 1: Data collection activities in Kogi
n
Baseline Endline
IDIs with policy makers 10 28
IDIs with PE/E survivors 5 6
IDIs with laboratory professionals - 6
FGDs with married men & women 4 4
Surveys with providers 74 73
Assessments of health facilities 8 60
Observations of ANC visits 15 266
POLICY INFLUENCE 
At endline, researchers interviewed 28 local government 
area (LGA) and state policy makers revealing mixed 
awareness of the national protocol on managing PE/E 
through task shifting to PHC providers. Though more 
local policy makers knew of the national protocol than at 
baseline, at least one LGA health manager did not know 
whether task shifting had been implemented in their 
area. Those who are aware of the protocol support task 
shifting to lower level cadres for PE/E management.  
“In general, [task-shifting and referral] is very 
good because it will help the pregnant women, it 
will help our patients.”
– LGA health manager, 2017
Policy makers are concerned about pregnant women 
registering late for ANC as a principle challenge in 
detecting and managing PE/E. Policy makers cite poverty 
and lack of information about ANC as barriers to women’s 
care-seeking behaviors.   
“Beginning with the antenatal services, some of 
them do not have the financial ability to access 
the services and some other persons, due to 
their literacy level, do not see the need to attend 
antenatal clinics. Some of the husbands do not 
allow their wives to attend antenatal clinics, and 
many of them do not keep to their appointments. 
They miss appointments due to one reason or the 
other.”
– LGA policy maker, 2018
FACILITY CAPACITY & PREPAREDNESS 
At baseline, researchers visited eight health facilities 
in Kogi and found that only one (13%) had guidelines 
available to manage PE, one had all vital ANC equipment, 
and four consistently used MgSO4 to treat PE/E.  At 
endline, researchers visited 48 primary and 12 secondary 
healthcare facilities and observed that 56 (93%) have 
available guidelines to manage PE (p<0.001).  
At baseline, only one out of eight facilities (13%) had all 
the necessary ANC equipment to detect PE/E; at endline, 
five out of 14 facilities (36%) had all equipment. At 
baseline, 75% of facilities reported capacity to procure 
MgSO4 and, of those, 50% asked clients to purchase the 
drug themselves. At endline, 59% of facilities purchased 
MgSO4 from local pharmacies, while only 13% asked 
clients to procure it themselves.
Though not statistically significant, the decrease in 
percent of clients who were asked to procure MgSO4 
themselves indicates that facilities are now better able to 
procure the drug than at baseline.    
Eighty-one percent of facilities at endline had MgSO4 
available on-site, compared to only 25% at baseline. Four 
(50%) facility managers said they always used MgSO4 at 
baseline, and at endline 22 (42%) managers reported 
always using MgSO4. At baseline, two (25%) facility 
managers said they sometimes use MgSO4 to manage 
PE/E, while at endline 12 (23%) report sometimes using 
it. Neither of these changes was statistically significant 
and percent decreases are likely due to sample size 
differences.  
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Figure 1: Facilities with key equipment to detect and manage PE/E and MgSO4 toxicity (%)
Researchers identified the number of facilities that 
stocked key equipment to detect and manage PE/E and 
treat MgSO4 toxicity. Improvements were observed at 
endline for stocking all key equipment except urine bags 
(Figure 1). 
A critical component of managing and treating severe 
PE/E is the capacity to conduct emergency obstetric and 
neonatal care (EmONC) by providing key signal functions 
and essential drugs to mothers throughout the pregnancy 
continuum (pregnancy, labor and delivery and postnatal). 
Of all facilities visited in Kogi State at endline, 14 (23%) 
stock all essential equipment, and 36 (60%) stock at 
least three-quarters of the essential supplies. Table 2 
compares facilities’ capacity to provide EmONC signal 
functions at baseline and endline.
PROVIDER KNOWLEDGE & SKILLS
At endline, 73 providers from primary and secondary 
facilities in Kogi State responded to questions about 
preventing, detecting, and treating PE/E. Providers can 
correctly identify and manage hypertension in pregnancy. 
Ninety percent of providers correctly diagnosed 
hypertension at endline compared to 86% at baseline, 
and significantly more providers use antihypertensive 
drugs to treat hypertension at endline compared to 
baseline (85% vs. 45%; p<0.001). 
A key component of task shifting from secondary to 
primary facilities is PHC providers’ capacity to prevent 
and manage PE/E using antihypertensive drugs, MgSO4, 
and calcium gluconate to treat MgSO4 toxicity. 
Figure 2 highlights knowledge improvement among PHC 
providers from baseline to endline.
This intervention is based on the Pritchard method for 
administering loading and maintenance doses of MgSO4 
to treat severe pre-eclampsia and prevent the onset of 
eclampsia. At baseline, 16% of providers could correctly 
describe the loading dose of MgSO4 and none knew the 
appropriate maintenance dose. At endline, 79% know the 
appropriate loading dose (p<0.001)) and more than half 
(52%) know the correct maintenance dose (p<0.001). 
Similarly, the number of providers who know the correct 
antidote to MgSO4 toxicity doubled from baseline to 
endline (32% to 64%, respectively, p=0.001). Kogi State 
was the only state where the number of providers able 
to correctly identify pre-eclampsia decreased (from 95% 
to 67%; p<0.001), though this may be attributed to a 
shorter intervention period in Kogi.
QUALITY OF CARE
Quality of care was assessed through 266 observations 
of client-provider interactions during ANC consultations, 
qualitative data from four men’s and women’s community 
FGDs, and six interviews with PE/E survivors. Figure 3 
compares the proportions of ANC components that clients 
received at baseline and endline. At baseline, virtually 
all clients had their blood pressure checked during the 
observed ANC visits. However, 76 clients (30%) did not 
have their urine tested for protein. 
Clients’ reports confirm findings from Figure 3 that BP, 
proteinuria, and weight screenings often occur during 
ANC. In an important contrast to baseline findings where 
no providers were observed discussing the symptoms of 
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Table 2: Signal functions for EmONC










antibiotics 7 6 56 52




7 6 43 26
Manual placenta 
removal 8 7 50 31
Retained products 
removal 6 6 43 26
Assisted vaginal 
delivery 7 7 38 33
Blood transfusion 7 7 22 19
Caesarean section 6 6 12 10
Neonatal 
rescuscitation 7 6 52 42
Figure 2: Providers’ knowledge of drugs for PE/E 
prevention and management (%)
impending eclampsia, women in Kogi State now report 
that, following BP and urine checks, they discuss with 
their providers the potential complications of high BP 
and proteinuria, specifically maternal or fetal death. Fifty-
two percent of providers were observed counseling their 
clients about referral processes for complications and 
delivery, and 95% of clients were given the opportunity to 
ask additional questions during their ANC visits.
Women report that they are well-treated in health facilities 
and seem to trust the health care system.
“When you get to the doctor - they care for you.”
– Pre-eclampsia survivor, 2018
“They treated us very well whenever we came 
because I delivered my baby through CS so they 
never treated us bad, they always treated us 
good.”
– Pre-eclampsia survivor, 2018
Laboratory staff report mixed experiences with supply 
stocks. While some facilities experience infrequent 
stock outs of dipsticks for proteinuria, likely due in part 
to regular oversight and procurement procedures, other 
facilities experience frequent stock outs and delayed 
replenishments.
“The materials, the laboratory consumables, the 
reagents we are using in the laboratory most 
of the problem we are having is from that area 
sometimes you write a request out for reagent it 
may take you about a month before you will be 
able to get the reagent pack.”
– Laboratory department head, PHC, 2018
 
“Urinalysis is not something you will have 
shortage of consumables because they are cheap 
and they are always readily available; I don’t know 
when last we were short of consumables.”
– Laboratory scientist, general hospital, 2018
COMMUNITY KNOWLEDGE & 
PERCEPTIONS
Community knowledge and perceptions of hypertension 
and related complications during pregnancy are mixed. 
Similar to baseline, men and women attribute the 
symptoms of hypertension to a woman’s over-thinking 
and fear, and religious leaders cite spiritual attack. 
Interestingly, men in Kogi State perceive the cause of 
hypertension to be a woman’s failure to attend ANC, 
while women (both FGD participants and PE/E survivors) 
overwhelmingly state that most women in Kogi State 
seek health services from ANC providers. 
Some community members describe a woman’s husband 
and mother-in-law as encouraging her to seek facility-
based care, while others say that husbands and mothers-
in-law may dismiss hypertension-related symptoms as 
signs of laziness or a woman’s “pretending.” 
At endline, community members report that some 
women seek facility-based care, while others continue 
to use herbal medications. Men and women in the 
community cite financial concerns as the primary barrier 
to women’s ANC attendance, though most survivors 
of PE/E say that finances were not a concern in her 
decision to go to the hospital for care. At endline, men 
and women have differing perceptions of religious 
leaders’ roles in the health system. Women report that 
religious leaders will simply pray for a woman’s health, 
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Figure 3: Clients who received 8 essential ANC components (%)
while men reported religious leaders act as barriers 
along the referral pathway by delaying women’s seeking 
care at facilities.  
“At times pastor tell them that they should be 
coming for prayer instead of advising them to 
visit the hospital for proper check-up. They will be 
deceiving them to be coming for prayer. That one 
will discourage them to visit the hospital.”
– Male FGD participant, 2018
SURVIVOR’S EXPERIENCES
While most survivors attended ANC, the timing and 
reasons for seeking care varied widely. One woman 
began ANC at two months to verify that she was pregnant 
and subsequently attended at least 10 ANC check-ups, 
while another survivor registered for ANC during her 8th 
month because she was experiencing headache and 
other symptoms, which she believed were due to malaria. 
Survivors consistently report that providers check their 
BP and urine, though BP test results are more frequently 
discussed than urine. A few women state their providers 
discussed with them the potential consequences of 
high BP or proteinuria during, including convulsion, and 
recommended a cesarean section (CS) delivery. 
“Like the day I delivered my baby, when I got there 
I explained to them that I am not okay and that I 
am feeling pain. So, they checked my BP… when 
the doctor saw the scan result, he said that my 
BP was too high, that they have to admit me; they 
also said my first CS was just two years ago and 
I have high BP so they cannot advise me to go 
through the pain of delivery. That if I have money 
they will advise me to still use CS. But before then 
they will calm my BP. So, they asked us to buy 
injection and tablets, and they used it all on me 
before taking me to the theater.”
– Pre-eclampsia survivor, 2018
DISCUSSION
Policy makers recognize the importance of scaling up task-
shifting of MgSO4 loading dose administration and referral 
to PHC providers, and see it as a means of overcoming 
barriers to hospital attendance. Facility capacity to 
detect, treat, and manage PE/E has improved. Fewer 
women are responsible for procuring their own MgSO4, 
which contributes to improving facility accessibility and 
affordability. More facilities in Kogi stocked all or most 
key equipment for detecting and managing pre-eclampsia 
and MgSO4 toxicity than in any other state. 
Sufficient supply chain commodities have implications 
for provider capacity, and provider capacity in Kogi State 
improved significantly when identifying and managing 
women with hypertension. Conversely, providers at 
endline were less able to correctly identify PE/E. This 
may be linked to the fact that Kogi State remained the 
comparison, non-intervention state for implementation. 
Focused re-training on PE/E identification at the 
community level, or supplemental training at the PHC level 
like those that occurred in Cross River and Ebonyi states, 
will further improve providers’ diagnostic knowledge 
retention and women’s uptake of care.  
Gender-based and intergenerational differences in 
community and survivor perceptions of key components of 
pregnancy care may affect ANC attendance and response 
to symptoms. Mixed use of traditional and facility-based 
health services and low integration of religious leaders 
into the health system offer opportunities for continued 
health education and community collaboration. 
One limitation of the data is the unequal sample sizes from 
ANC observations at baseline and endline. The duration 
of the intervention was relatively short (14 months); a 
longer period may have demonstrated further increase in 
provider knowledge and confidence in practices around 
PE/E care. However, triangulating across different data 
sources and types renders our study findings robust.
RECOMMENDATIONS
• Sustain support for supply chain procurement and
linkages to existing distribution system;
• Re-train providers at primary and secondary levels
to correctly identify pre-eclampsia, incorporating
antihypertensive drugs training that was previously
implemented in Ebonyi State;
• Continue mentoring efforts and supportive
supervision for PHC providers to detect and manage
hypertensin in pregnancy, including PE/E; and
• Expand community health education about the
causes, signs, symptoms, and complications of
hypertension during pregnancy, with particular
emphasis given to engaging pre-existing women’s
and other community groups.
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